Atrial Fibrillation: Beyond Rate Control

Subir Bhatia, Alan Sugrue, Samuel J Asirvatham

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Atrial fibrillation is the most common cardiac dysrhythmia encountered in the primary care setting. Although a rate control strategy is pursued by physicians for the initial treatment of atrial fibrillation, the efficacy of a rhythm control approach is often undervalued despite offering effective treatment options. There are many pharmacological therapies available to patients, with drug choice often dictated by safety concerns (toxicities and proarrhythmic adverse effects) as well as patient characteristics and comorbidities. This article presents a simplified approach to understanding the rhythm control strategy, including the advantages and disadvantages of various antiarrhythmic drugs and common drug-drug interactions encountered in the primary care setting.

Original languageEnglish (US)
Pages (from-to)373-380
Number of pages8
JournalMayo Clinic Proceedings
Volume93
Issue number3
DOIs
StatePublished - Mar 1 2018

Fingerprint

Atrial Fibrillation
Primary Health Care
Anti-Arrhythmia Agents
Drug Interactions
Pharmaceutical Preparations
Comorbidity
Cardiac Arrhythmias
Therapeutics
Pharmacology
Physicians
Safety

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Atrial Fibrillation : Beyond Rate Control. / Bhatia, Subir; Sugrue, Alan; Asirvatham, Samuel J.

In: Mayo Clinic Proceedings, Vol. 93, No. 3, 01.03.2018, p. 373-380.

Research output: Contribution to journalReview article

Bhatia, Subir ; Sugrue, Alan ; Asirvatham, Samuel J. / Atrial Fibrillation : Beyond Rate Control. In: Mayo Clinic Proceedings. 2018 ; Vol. 93, No. 3. pp. 373-380.
@article{3efd506593a34529aed7fd52d45332cb,
title = "Atrial Fibrillation: Beyond Rate Control",
abstract = "Atrial fibrillation is the most common cardiac dysrhythmia encountered in the primary care setting. Although a rate control strategy is pursued by physicians for the initial treatment of atrial fibrillation, the efficacy of a rhythm control approach is often undervalued despite offering effective treatment options. There are many pharmacological therapies available to patients, with drug choice often dictated by safety concerns (toxicities and proarrhythmic adverse effects) as well as patient characteristics and comorbidities. This article presents a simplified approach to understanding the rhythm control strategy, including the advantages and disadvantages of various antiarrhythmic drugs and common drug-drug interactions encountered in the primary care setting.",
author = "Subir Bhatia and Alan Sugrue and Asirvatham, {Samuel J}",
year = "2018",
month = "3",
day = "1",
doi = "10.1016/j.mayocp.2017.10.024",
language = "English (US)",
volume = "93",
pages = "373--380",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "3",

}

TY - JOUR

T1 - Atrial Fibrillation

T2 - Beyond Rate Control

AU - Bhatia, Subir

AU - Sugrue, Alan

AU - Asirvatham, Samuel J

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Atrial fibrillation is the most common cardiac dysrhythmia encountered in the primary care setting. Although a rate control strategy is pursued by physicians for the initial treatment of atrial fibrillation, the efficacy of a rhythm control approach is often undervalued despite offering effective treatment options. There are many pharmacological therapies available to patients, with drug choice often dictated by safety concerns (toxicities and proarrhythmic adverse effects) as well as patient characteristics and comorbidities. This article presents a simplified approach to understanding the rhythm control strategy, including the advantages and disadvantages of various antiarrhythmic drugs and common drug-drug interactions encountered in the primary care setting.

AB - Atrial fibrillation is the most common cardiac dysrhythmia encountered in the primary care setting. Although a rate control strategy is pursued by physicians for the initial treatment of atrial fibrillation, the efficacy of a rhythm control approach is often undervalued despite offering effective treatment options. There are many pharmacological therapies available to patients, with drug choice often dictated by safety concerns (toxicities and proarrhythmic adverse effects) as well as patient characteristics and comorbidities. This article presents a simplified approach to understanding the rhythm control strategy, including the advantages and disadvantages of various antiarrhythmic drugs and common drug-drug interactions encountered in the primary care setting.

UR - http://www.scopus.com/inward/record.url?scp=85042303717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042303717&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2017.10.024

DO - 10.1016/j.mayocp.2017.10.024

M3 - Review article

C2 - 29502567

AN - SCOPUS:85042303717

VL - 93

SP - 373

EP - 380

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 3

ER -